VERAPHARM: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VERAPHARM
Largest movements
- Tangible fixed assets +€28,938
up €28,938 (+61.7%), from €46,896 to €75,835
of which Plant, machinery and equipment: +€36,333
- Cash -€27,619
down €27,619 (-17.9%), from €153,901 to €126,282
mainly Investment in fixed assets (net) (-€43,252) and Other debts (-€31,487)
- Stocks and contracts +€7,943
up €7,943 (+9.6%), from €82,538 to €90,481
- Receivables within one year -€4,861
down €4,861 (-15.0%), from €32,369 to €27,508
of which Trade receivables: -€15,310
- Other debts -€31,487
down €31,487 (-47.1%), from €66,908 to €35,421
- Reserves +€26,168
up €26,168 (+14.0%), from €187,581 to €213,749
- Trade debts +€10,459
up €10,459 (+23.8%), from €43,990 to €54,450
- Gross operating margin -€6,670
down €6,670 (-6.6%), from €101,728 to €95,058
- Depreciation +€4,481
up €4,481 (+45.6%), from €9,833 to €14,314
- Taxes -€3,569
down €3,569 (-28.3%), from €12,612 to €9,043
- Staff costs +€3,183
up €3,183 (+22.5%), from €14,177 to €17,360
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €320,785 | €327,020 | +€6,235 | +1.9% |
| Fixed assets | 21/28 | €47,396 | €76,335 | +€28,938 | +61.1% |
| Tangible fixed assets | 22/27 | €46,896 | €75,835 | +€28,938 | +61.7% |
| Plant, machinery and equipment | 23 | €21,570 | €57,904 | +€36,333 | +168.4% |
| Furniture and vehicles | 24 | €25,326 | €17,931 | -€7,395 | -29.2% |
| Financial fixed assets | 28 | €500 | €500 | = | 0.0% |
| Current assets | 29/58 | €273,389 | €250,685 | -€22,703 | -8.3% |
| Stocks and contracts in progress | 3 | €82,538 | €90,481 | +€7,943 | +9.6% |
| Stocks | 30/36 | €82,538 | €90,481 | +€7,943 | +9.6% |
| Amounts receivable within one year | 40/41 | €32,369 | €27,508 | -€4,861 | -15.0% |
| Trade receivables | 40 | €32,211 | €16,901 | -€15,310 | -47.5% |
| Other amounts receivable | 41 | €158 | €10,606 | +€10,448 | +6616.7% |
| Cash at bank and in hand | 54/58 | €153,901 | €126,282 | -€27,619 | -17.9% |
| Deferred charges and accrued income | 490/1 | €4,581 | €6,414 | +€1,833 | +40.0% |
| Total equity and liabilities | 10/49 | €320,785 | €327,020 | +€6,235 | +1.9% |
| Equity | 10/15 | €206,181 | €232,349 | +€26,168 | +12.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €187,581 | €213,749 | +€26,168 | +14.0% |
| Distributable reserves | 133 | €187,581 | €213,749 | +€26,168 | +14.0% |
| Amounts payable | 17/49 | €114,604 | €94,671 | -€19,933 | -17.4% |
| Amounts payable within one year | 42/48 | €114,464 | €92,655 | -€21,810 | -19.1% |
| Trade debts | 44 | €43,990 | €54,450 | +€10,459 | +23.8% |
| Suppliers | 440/4 | €43,990 | €54,450 | +€10,459 | +23.8% |
| Taxes, remuneration and social security | 45 | €3,566 | €2,784 | -€782 | -21.9% |
| Taxes | 450/3 | €1,119 | €229 | -€890 | -79.5% |
| Remuneration and social security | 454/9 | €2,448 | €2,555 | +€107 | +4.4% |
| Other amounts payable | 47/48 | €66,908 | €35,421 | -€31,487 | -47.1% |
| Accrued charges and deferred income | 492/3 | €140 | €2,016 | +€1,876 | +1341.9% |
| Remuneration, social security and pensions | 62 | €14,177 | €17,360 | +€3,183 | +22.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,833 | €14,314 | +€4,481 | +45.6% |
| Other operating charges | 640/8 | €3,278 | €2,634 | -€644 | -19.6% |
| Gross operating margin | 9900 | €101,728 | €95,058 | -€6,670 | -6.6% |
| Operating profit (loss) | 9901 | €74,440 | €60,749 | -€13,691 | -18.4% |
| Financial income | 75/76B | €758 | €725 | -€33 | -4.4% |
| Recurring financial income | 75 | €758 | €725 | -€33 | -4.4% |
| Financial charges | 65/66B | €14,526 | €15,181 | +€655 | +4.5% |
| Recurring financial charges | 65 | €14,526 | €15,181 | +€655 | +4.5% |
| Profit (loss) for the period before taxes | 9903 | €60,672 | €46,292 | -€14,379 | -23.7% |
| Income taxes | 67/77 | €12,612 | €9,043 | -€3,569 | -28.3% |
| Profit (loss) for the period | 9904 | €48,060 | €37,249 | -€10,811 | -22.5% |
| Profit (loss) for the period to be appropriated | 9905 | €48,060 | €37,249 | -€10,811 | -22.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.